Assuming mid-Dec payment, this is trading at a reasonable gross/annualised spread of 4.9%/12.6%. Also run a ruler over other NZ peers such as Ryman Healthcare, Oceania Healthcare, and Summerset .
What is covered in the Full Insight:
Introduction to Stonepeak's Offer
Key Financial Details and Valuation
Regulatory Approvals and Timeline
Shareholder Voting and Support
Conclusion and Trade Considerations
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.